A groundbreaking study has unveiled potential concerns regarding semaglutide, the active ingredient in popular weight loss medications like Ozempic and Wegovy. The research suggests a possible ...

Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

The debate over whether GLP-1 medications raise the risk of eye conditions that could lead to vision loss continues. Scientists have been closely studying this association as more people turn to these ...

(NewsNation) — A small number of patients taking GLP-1 weight loss medications have experienced loss of vision but researchers say they have not established a direct link to the drugs. A new study ...

Weight-loss drugs may cause serious eye diseases leading to vision loss in some people, two new studies suggest. One study, published in JAMA, assessed data from nearly 1.5 million people and found ...

PICKING up her phone, Oonagh Van der Berg goes to read a WhatsApp message – but the 45-year-old, from Belfast, can’t focus.

A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used drugs Ozempic and Wegovy, following a recent study that suggests a link between the medications and a sudden, ...

Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...